Public Law 115-97 (formerly known as H.R. 1, Tax Cuts and Jobs Act) Implementation 
Draft legislation relating to economic activity in Puerto Rico
International tax issues, including OECD digital taxation work program Patent litigation reform issues and issues related to post-grant proceedings at the PTO
Value of intellectual property H.R. 1425, Patient Protection and Affordable Care Enhancement Act - provisions relating to pharmaceutical price controls
H.R.6383, Uterine Fibroid Research and Education Act of 2020
H.R.7647 - To provide for a COVID-19-related delay regarding annual limitation on cost-sharing for group health plans and individual and small group health insurance coverage.
340B drug discount program policy issues
Drug cost and pricing policy issues
Patient affordability issues
Policy proposals relating to clinical trial diversity
Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2021; Notice Requirement for Non-Federal Governmental Plans proposed rule H.R. 3: Lower Drug Costs Now Act of 2019 - Provisions related to prescription drug pricing, foreign reference pricing, Part D, manufacturer rebates, and other provisions
H.R. 19: Lower Costs, More Cures Act of 2019 - Provisions related to prescription drug pricing, transparency, manufacturer rebates and other provisions
S. 1895: Lower Health Care Costs Act - Provisions related to prescription drug pricing, transparency and patent issues
S. 2543, Prescription Drug Pricing Reduction Act of 2019 - Provisions related to Medicare Part D, Medicaid, and drug pricing
S. 2911, Seniors Prescription Drug Relief Act of 2019 - Provisions related to Medicare Part D and Medicaid rebates
S. 3129: Lower Costs, More Cures Act of 2019 - Provisions related to prescription drug pricing, transparency, manufacturer rebates and other provisions
Executive Order 13948, White House Executive Order on Lowering Drug Prices by Putting America First
Executive Order 13938, White House Executive Order on Increasing Drug Importation to Lower Prices for American Patients
Executive Order 13939, White House Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen
Policy Proposals related to Medicare Part D and patient cost-sharing
Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues
Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization
Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in
Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements USMCA and related policy issues
Policy proposals impacting biopharmaceutical supply chain
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid TRD - Trade (domestic/foreign)
14 - Council of Economic Advisers (CEA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 14 - Council of Economic Advisers (CEA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 14 - Council of Economic Advisers (CEA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 14 - Council of Economic Advisers (CEA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 14 - Council of Economic Advisers (CEA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ABBVIE, INC.
1399 New York Avenue NW, Suite 600, Washington, DC, 20005, US
DANIEL BACHNER STEPHEN SCANGO DANIEL BACHNER STEPHEN SCANGO BINTA BEARD STEPHEN SCANGO DANIEL BACHNER BINTA BEARD STEPHEN SCANGO DANIEL BACHNER BINTA BEARD DANIEL BACHNER STEPHEN SCANGO